Palabras clave: Enfermedad de las arterias coronarias, polimorfismo genético, rayos X de reparación de complementación cruzada grupo 1
para la reparación por escisión de la base (REB) y la reparación de roturas simples de cadenas (RSC).

Métodos: La población de estudio consistió en 402 participantes que vivían en la misma región, y que fueron clasificados en el grupo de caso (n = 201) y el grupo de control (n = 201
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INTRODUCTION
Coronary artery disease (CAD), is a major cause of disability and sudden death all over the world (1) . Epidemiological studies have shown that CAD incidence frequency in Turkey is 5.1 per thousand among males and 3.4 per thousand among females (2). An inflammatory disease, CAD is characterized by a modification of atherosclerotic plaques, calcified regions, modified lipids, inflamed smooth muscle cells, endothelial cell, leukocytes and foam cells (3) . Genetic polymorphisms in DNA repair genes may be associated with differences in DNA repair capacity and may influence an individual's risk of atherosclerosis.
X-ray repair cross complementing 1 gene (XRCC1), a DNA repair gene, plays an important role in base excision. This gene consists of 17 exons and is located on chromosome 19q 13.2-13.3, with a length of 33 kilobase. The XRCC1 gene encodes DNA-repair proteins, which interact with other proteins such as Lig3, Polb and PARP, creating a complex involved in short patch BER [base excision repair] (4). This study concentrated on two polymorphisms of XRCC1: codon 194 and codon 399. One of these two polymorphisms, namely codon 194, is "an arginine (Arg) to tryptophan (Trp) change" (Arg194Trp). The X-ray repair cross complementing 1, Arg399Gln polymorphism is located in the area coding for the binding side of poly (ADP-ribose) polymerase [PARP] . Poly (ADP-ribose) polymerase is a zinc-finger containing enzyme that detects DNA strand breaks (5) . In this scope, this study aimed to investigate the association between XRCC1 Arg194Trp and Arg399Gln polymorphisms and CAD. This is the first study investigating the association between this polymorphism and demographic parameters in Turkish population.
METHODS
Study Population: After approval by the Ethics Committee of the Medical School of Cumhuriyet Universty, data of 201 cases and 201 controls were analysed (Number of Ethical Committee 2011-02/04). Control and case groups are composed of Özbilüm's previous study; because this study is a continuation of our previous studies; we selected cases and the control group based on our previous publication (6) .
Genotyping: Blood samples (2 mL) were collected into EDTA tubes. Leukocytes DNA (100 ng) were extracted using standard phenol-chloroform methods was used as a template in PCR-based restriction fragment length polymorphism (RFLP) assays.
Polymerase chain reaction-restriction fragment length polymorphism condition is carried out based on a previous publication (7) . Polymerase chain reaction-restriction fragment length polymorphism analyses of XRCC1 Arg194Trp and Arg399Gln polymorphism are shown in Figure. Ten per cent of the study population was further confirmed for each genotype via direct sequencing, using an ABI PRISM 377 automatic sequencer (Applied Biosystems).
Statistical analysis: Statistical analysis was performed using SPSS 14.0 (SPSS Inc., Chicago, IL, USA) and EH for haplotype (8) . Pearson's Chi-square test was used to calculate the statistical significance of the differences in genotypes and demographic and clinical parameters of the case and the control group participants. T-test was made to evaluate the age distribution of the case and the control group populations. Multivariate logistic regression analysis (adjusted for all demographic and clinical parameters) was performed to assess the independent contribution of genotype to CAD. X-ray repair cross complementing 1 gene and Arg399Gln polymorphism was also adjusted for demographic parameters as well. For each odds ratio (OR), confidence interval (CI) was calculated to be 95%. In all cases, statistical significance was set at p ≤ 0.05. Table 1 shows the demographic and clinical parameters of the study population. A total of 201 patients with CAD and 201 healthy control subjects were included in this study. Demographic parameters were found to be statistically significantly different between the case and the control group's subjects, except for age and diabetic mellitus (Table 1) . Table 2 presents the Arg194Trp and Arg399Gln allele and genotype distributions of study groups. No statistically significant difference was detected between the case and the control groups in terms of allele and genotype frequencies in Arg194Trp (Table 2) . Gln frequency in Arg399Gln polymorphism were found to statistically significantly differ (p = 0.003; OR = 1.56).
RESULTS
Comparison of the Arg/Arg genotype with Gln/Gln genotypes produced a statistically significant difference between case and the control groups (p = 0.017; OR=1.98). Comparison between the Arg399Gln geno-type and wild genotype also revealed a statistically significant difference between the study groups (p = 0.013; OR = 1.73). The study also revealed four possible haplotypes with no statistically significant difference between the case and the control groups (Table 2 ). Table 3 also shows risk estimates and genotype frequencies for all demographic parameters in Arg399Gln polymorphism. Comparison of the Arg/Arg genotype with both Arg/Gln and Gln/Gln genotypes produced a statistically significant difference between the male CAD patients and the control group participants (p = 0.005; OR = 2.49; p = 0.009; OR = 3.00, respectively).
DISCUSSION
Coronary artery disease, a multifactorial disease, originates from an interaction between environmental influences and genetic tendencies (9) . DNA damages are observed in both circulating cells and atherosclerotic plaques of patients with CAD (10) . Some studies suggest that DNA alterations are present in atherosclerotic tissues and may play a critical role in initialization of this disease (11) . The X-ray repair cross complementing 1 gene, is a major gene in the base excision repair (BER) system, interacting with several BER enzymes to modify and stabilize their activity (12) .
The present study tested the hypothesis whether SNPs in the genes encoding different DNA repair enzymes interact with CAD risk. While the allele frequency of XRCC1 194Trp in the present study was calculated to be 8.96% in the control group (Table 2) , it was reported as 6.48% in the Czech Republic (13) and 8.47% in the United States of America (14) . In a study investigating the relationship between CAD polymorphism and Arg194Trp polymorphism, Bazo (15) et al determined Trp allele frequency as 2.6% in a Brazilian population.
Results of the present study agree with the results of the latter study as both studies did not reveal any relationship between this polymorphism and CAD.
The present study revealed a relation between XRCC1399 Gln/Gln genotype and CAD patients compared with healthy individuals (p = 0.017): the individuals with Gln/Gln genotype have approximately three-times greater CAD risk compared to those carrying Arg/Arg genotype (adj OR = 3.11) and there is a statistically significant difference in Arg399Gln allele distributions between CAD patients and the control group (p = 0.003).
There was a significant association between Arg399Gln polymorphism and CAD in different ethnic groups (15, 16) . On the contrary, some studies previously carried out in Turkey did not show a statistically significant relationship between CAD and Arg399Gln polymorphism (17) . The X-ray repair cross complementing 1 gene, polymorphism was also found to have a statistically significant association with many types of diseases in a Turkish population (18) . The X-ray repair cross complementing 1 gene protein interacts with PARP's central domain. This domain has codon 301-402; therefore, codon 399 is within this binding region. The X-ray repair cross complementing 1 gene 399Gln allele is linked to decreased BER mechanism.
Thus, Arg399Gln polymorphism is thought to be associated with reduced DNA repair efficiency (19) . On the other hand, increased DNA damage plays an important role in the early phases of atherogenesis. DNA damage causes smooth muscle cell proliferation in the intima of arteries. This is the first study examining haplotype frequencies by linkage analysis. Although no relationship was found between the case and control haplotype frequencies, TG haplotype was recorded to be associated with increased CAD risk (Adj OR = 2.41).
Since Arg399Gln polymorphism is significant for CAD; this study, for the first time, analysed the relationship between genotype frequencies and demographic parameters for Arg399 in a Turkish population (Table 3) . This analyses produced a statistically significant difference in distribution of genotype frequency among male participants (p = 0.009). Due to some risk and hormonal factors effective during development periods of males and females (20) , male individuals had two-times higher-risk than female individuals of CAD [for male OR = 3.00; for female OR = 1.27] ( Table 3) . Findings of the present study confirmed that smoking is an important risk factor for CAD since smoker frequency is higher than non-smoker frequency in the case group (Table1). Table 3 presented genotype distribution frequency between Arg399Gln and CAD in smokers. Smokers with Gln/Gln genotype have 2.11 times higher-risk than those with Arg/Arg genotype for XRCC1 Arg399Gln. Recent studies have supported the mutagenic and mitogenic role played in atherosclerosis by the chemicals in cigarette smoke. Moreover, there is growing evidence that DNA damage is not only confined to cancer patients but also present in cardiovascular disease patients (21) . Cigarette contains some chemicals that produce free radicals which induce oxidative damage to DNA. Weng et al (22) indicated smoking status and age as important variables affecting individuals' basal DNA damage in XRCC1 194 and 399.
The present study also analysed the relationship between Arg399Gln and hypertensive CAD individuals. A statistically significant difference was found between the case and the control group in Arg399Gln (Table 3) .
Yu et al (23) found no significant relationship between Arg399Gln and hypertensive CAD patients. These conflicting results may be related to differing ethnic groups and sample sizes. Hypertension is one of the most prevalent population risk factors, especially in patients with established CAD (24) .
A limitation of the study is that the sample size could have been larger. There was a statistically significant difference between the case and control groups in terms of gender, smoking status, hypertension and hypercholesterolaemia. In our study, frequency of male patients was found to be higher than female patients as seen in other studies. Similar to gender, smoking status, hypercholesterolaemia and hypertension are risk factor for CAD, so in general population frequencies of these parameters are high in our population.
In conclusion, XRCC1 Arg399Gln polymorphism has been found to be statistically significant for CAD. This study also revealed a statistically significant association between XRCC1 399Gln/Gln genotype and CAD in males, smokers and hypertensive individuals. Thus, XRCC1 399Gln/Gln genotype may be a significant risk factor for CAD.
